Endometriosis News

The relugolix combination therapy known as Myfembree provided long-term benefits in women with uterine fibroids and significantly improved daily functioning in women with endometriosis, data from two studies showed.

Botulinum toxin relieved chronic pelvic pain caused by endometriosis, according to data from a small randomized controlled trial presented at the American Society of Reproductive Medicine Scientific Congress & Expo.

Middle-aged women with endometriosis took more sick days and exhibited poor work ability compared with those without , according to a Finnish study.

Transvaginal ultrasound used to determine appropriateness of endometrial cancer biopsy missed nearly five times more cases of the disease among Black women vs. white women, according to a simulated cohort study published in JAMA Oncology.

Recent data revealed an association between circadian rhythm misalignment and an increased risk for ovarian endometriosis. A review of the findings was the top story in endocrinology last week.

Women with circadian rhythm misalignment may be at a greater risk for developing ovarian endometriosis, according to data presented at the European Congress of Endocrinology.

Women with endometriosis were at increased risk for certain types of CVD, according to a study of nearly 280,000 patients aged 16 to 50 years in the United Kingdom.

March is National Endometriosis Awareness Month. The observance was founded by the Endometriosis Association in 1993 and has since become recognized worldwide, according to the association.

NASHVILLE — Endometriosis, long thought to be solely a painful condition resulting in painful lesions in the peritoneal cavity, should really be thought of, and managed, much differently, according to a presenter at the American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting.

Endometriosis affects 6% to 10% of women of reproductive age, according to the American College of Obstetricians and Gynecologists. And by some estimates, endometriosis has direct costs of $12,118 per patient, per year in the United States.